Fda

Latest Stories

In this photo made with a long exposure, a man is silhouetted against lights reflected in the waters off Cape Neddick in Maine on Dec. 11, 2017. Federal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The advisers to the Food and Drug Administration are scheduled to vote on the drug's safety and effectiveness Tuesday, June 4, 2024, potentially setting the stage for federal approval later this year. (AP Photo/Robert F. Bukaty, File)

FDA rejects psychedelic drug therapy for PTSD

By Alex Miller - The Washington Times

Anti-abortion protesters demonstrate outside the Supreme Court on Thursday, June 13, 2024, in Washington. The Supreme Court on Thursday unanimously preserved access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court's first abortion decision since conservative justices overturned Roe v. Wade two years ago. (AP Photo/Mark Schiefelbein)

Supreme Court dismisses challenge to abortion pill, says pro-life doctors lack standing

By Alex Swoyer and Stephen Dinan - The Washington Times

$FILE - People march through downtown Amarillo to protest a lawsuit to ban the abortion drug mifepristone, Feb. 11, 2023, in Amarillo, Texas. The Supreme Court will again wade into the fractious issue of abortion when it hears arguments Tuesday, March 26, 2024, over mifepristone, a medication used in the most common way to end a pregnancy, for a case with profound implications for millions of women no matter where they live in America and, perhaps, the race for the White House. (AP Photo/Justin Rex, File)$

Mail-order abortion scheme prioritizes politics, not health care

By Emily Erin Davis – Special to Higher Ground

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. Drugstore chains CVS Health and Walgreens plan to start dispensing the abortion pill mifepristone in a few states. CVS Health will start filling prescriptions for the medication in Rhode Island and neighboring Massachusetts “in the weeks ahead,” spokeswoman Amy Thibault said Friday, March 1, 2024. (AP Photo/Allen G. Breed, File)

New fight for life: Chemical abortion access threatens vulnerable women

By S. Ernie Walton – Special to Higher Ground

Varieties of disposable flavored electronic cigarette devices manufactured by EB Design, formerly known as Elf Bar, are displayed at a store in Pinecrest, Fla., Monday, June 26, 2023. U.S. officials are seizing more shipments of unauthorized electronic cigarettes. But industry data shows thousands of new flavored products continue pouring into the country from China. (AP Photo/Rebecca Blackwell, File)

U.S. seizes more illegal e-cigarettes, but new ones are launching

By Matthew Perrone - Associated Press

Bottles of the drug misoprostol sit on a table at the West Alabama Women's Center, March 15, 2022, in Tuscaloosa, Ala. White House officials warned on Wednesday, April 12, 2023, that access to nearly any medication is in jeopardy after a federal judge ordered that mifepristone, a pill commonly used for abortions, be pulled off the market, and they said they're consulting with lawmakers, doctors and pharmacies to fight the ruling. (AP Photo/Allen G. Breed, File)

Justice Department to take abortion pill fight to Supreme Court

By Alex Swoyer - The Washington Times

The Supreme Court is seen on Feb. 21, 2023, in Washington. The Supreme Court on Monday, April 3, declined to hear an appeal from a Louisiana death row inmate seeking a new sentencing hearing, over a dissent from the three liberal justices. (AP Photo/Alex Brandon) **FILE**

Abortion issue returns to Supreme Court as DOJ fights ruling on FDA’s pill approval

By Alex Swoyer and Valerie Richardson - The Washington Times

COVID-19 deaths illustration by Linas Garsys / The Washington Times

FDA should approve more therapeutics to prevent COVID-19 deaths

By Dr. Erik R. Swenson

A Juul electronic cigarette sign hangs in the front window of a bodega convenience store in New York City on June 25, 2022. In a deal announced Tuesday, Sept. 6, 2022, electronic cigarette maker Juul Labs will pay nearly $440 million to settle a two-year investigation by 33 states into the marketing of its high-nicotine vaping products, which have long been blamed for sparking a national surge in teen vaping. (AP Photo/Ted Shaffrey, File)

Juul settlement will cost e-cigarette producer nearly $440 million, ban youth marketing

By Brad Matthews - The Washington Times

A sign for the Food and Drug Administration is seen in Silver Spring, Md., on Thursday, Dec. 10, 2020. On Wednesday, June 15, 2022, an FDA advisory panel endorsed COVID-19 vaccines for use in kids ages 6 months to 4 years, meaning the youngest Americans should be eligible for the shots by next week. (AP Photo/Manuel Balce Ceneta) **FILE**

The FDA’s mass murder of more than half a million Americans

By Peter Navarro and Dr. Steven Hatfill

This 2018 photo provided by Amylyx shows the company's co-founders Joshua Cohen, left, and Justin Klee in Cambridge, Mass. On Friday, Sept. 2, 2022, federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, even as they're set to give its maker, Amylyx, a rare second chance to make its case publicly. (Amylyx via AP)

FDA still skeptical of ALS drug ahead of high-stakes meeting

By Matthew Perrone - Associated Press

Cigarettes Bad, Nicotine Okay Illustration by Greg Groesch/The Washington Times

Nicotine is not the devil, cigarettes are

By Dr. Jasjit Ahluwalia

In this Dec. 20, 2018, file photo Juul products are displayed at a smoke shop in New York. The Food and Drug Administration is poised to order JUUL e-cigarettes off the U.S. market after years of scrutiny over company marketing practices and fears its products fueled the youth vaping crisis, according to a report in the Wall Street Journal. (AP Photo/Seth Wenig, File) **FILE**

FDA’s war on nicotine puts ideology over science

By Tim Andrews

Shelves typically stocked with baby formula sit mostly empty at a store in San Antonio, Tuesday, May 10, 2022. A massive baby formula recall, combined with COVID-related supply chain problems, is getting most of the blame for the shortage that's causing distress for many parents across the U.S. But the nation's formula supply has long been vulnerable to this type of crisis, experts say, due to decades-old rules and policies that have allowed a handful of companies to corner nearly the entire U.S. market. (AP Photo/Eric Gay, File)

Operation Fly Formula flops as White House intervention fails to fill store shelves

By Susan Ferrechio and Tom Howell Jr. - The Washington Times

Medical device cybersecurity illustration by Linas Garsys / The Washington Times

Responsibility for health and medical device cybersecurity must be shared

By Peter J. Pitts

Illustration on FDA nicotine policy by Linas Garsys/The Washington Times

How FDA’s Mitch Zeller blew it on nicotine policy

By Amanda Wheeler

In this Wednesday, May 12, 2021, file photo, U.S. Rep. Marjorie Taylor Greene, R-Ga., speaks during a news conference on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin, File) **FILE**

MTG sparks controversy with more Nazi comparisons

By Joseph Clark - The Washington Times

Promising therapies for terminal patients advance while approval remains stagnant

By U.S. Sen. Mike Braun

This Dec. 17, 2019, file photo shows a group of cigarettes in New York. (AP Photo/Patrick Sison) ** FILE **

Nicotine and menthol prohibitions will endanger lives

By Tim Andrews

An ambulance carrying a patient drives past a Coronavirus awareness poster on a deserted street on the first day of a six-day lockdown put into place to control the rising cases of coronavirus infections, in New Delhi, India, Tuesday, April 20, 2021. India recorded over 250,000 new infections and over 1,700 deaths in the past 24 hours alone, and the U.K. announced a travel ban on most visitors from the country this week. (AP Photo/Manish Swarup)

The Latest: New Mexico preparing for ‘vaccine hesitancy’

By The Associated Press - Associated Press